147 results on '"ONCOL 3: Translational research NCMLS 3: Tissue engineering and pathology."'
Search Results
2. Diagnosing and classifying malignant lymphomas is improved by referring cases to a panel of expert pathologists.
3. Indium-111-labeled girentuximab immunoSPECT as a diagnostic tool in clear cell renal cell carcinoma.
4. Robotic injection of zebrafish embryos for high-throughput screening in disease models.
5. A 'complicated' fracture; a Philadelphia-chromosome positive myeloid sarcoma of the bone.
6. The dutch surgical colorectal audit.
7. Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma.
8. Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic review.
9. Application of Monoclonal Antibody G250 Recognizing Carbonic Anhydrase IX in Renal Cell Carcinoma.
10. Primary intracranial germ-cell tumors in adults: a practical review.
11. Trends in incidence, therapy and outcome of localized nodal and extranodal marginal zone lymphomas: declining incidence and inferior outcome for gastrointestinal sites.
12. European consensus conference for external quality assessment in molecular pathology.
13. Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program.
14. Undertreatment of patients with localized extranodal compared with nodal diffuse large B-cell lymphoma.
15. Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study.
16. Colorectal cancer: Is the new era of colorectal cancer classification finally here?.
17. Potential role of genetic markers in the management of kidney cancer.
18. ImmunoPET Imaging of Renal Cell Carcinoma with (124)I- and (89)Zr-Labeled Anti-CAIX Monoclonal Antibody cG250 in Mice.
19. T(14;18)(q32;q21) involving MALT1 and IGH genes occurs in extranodal diffuse large B-cell lymphomas of the breast and testis.
20. The evaluation of colon biopsies using virtual microscopy is reliable.
21. Implementation of a multi-institutional diffuse intrinsic pontine glioma autopsy protocol and characterization of a primary cell culture.
22. To publish or perish.
23. The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells.
24. Evaluating the validity of quality indicators for colorectal cancer care.
25. Accurate classification of childhood brain tumours by in vivo (1)H MRS - a multi-centre study.
26. MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.
27. Phase 1 Radioimmunotherapy Study with Lutetium 177-labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma.
28. MGMT-STP27 methylation status as predictive marker for response to PCV in anaplastic Oligodendrogliomas and Oligoastrocytomas. A report from EORTC study 26951.
29. Dual contrast agent for computed tomography and magnetic resonance hard tissue imaging.
30. Multivoxel 1H MR spectroscopy is superior to contrast-enhanced MRI for response assessment after anti-angiogenic treatment of orthotopic human glioma xenografts and provides handles for metabolic targeting.
31. Effects of Dual Targeting of Tumor Cells and Stroma in Human Glioblastoma Xenografts with a Tyrosine Kinase Inhibitor against c-MET and VEGFR2.
32. Pheochromocytoma and gastrointestinal stromal tumors in patients with neurofibromatosis type I.
33. Cancer, or not.
34. New developments in the pathology of malignant lymphoma: a review of the literature published from January 2013 to April 2013.
35. Increased mitochondrial activity in a novel IDH1-R132H mutant human oligodendroglioma xenograft model: in situ detection of 2-HG and alpha-KG.
36. A common variant at 8q24.21 is associated with renal cell cancer.
37. Significance of complete 1p/19q co-deletion, IDH1 mutation and MGMT promoter methylation in gliomas: use with caution.
38. Reply to John Samuel Banerji's Letter to the Editor re: Constantijn H.J. Muselaers, Otto C. Boerman, Egbert Oosterwijk, Johannes F. Langenhuijsen, Wim J.G. Oyen, Peter F.A. Mulders. Indium-111-Labeled Girentuximab ImmunoSPECT as a Diagnostic Tool in Clear Cell Renal Cell Carcinoma. Eur Urol 2013;63:1101-6.
39. Molecular imaging and carbonic anhydrase IX-targeted radioimmunotherapy in clear cell renal cell carcinoma.
40. KRAS mutation analysis on low percentage of colon cancer cells: the importance of quality assurance.
41. ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study.
42. Discordance in ERalpha, PR and HER2 receptor status across different distant breast cancer metastases within the same patient.
43. Homing characteristics of donor T cells after experimental allogeneic bone marrow transplantation and posttransplantation therapy for multiple myeloma.
44. MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program.
45. Zero echo time magnetic resonance imaging of contrast-agent-enhanced calcium phosphate bone defect fillers.
46. Expression and clinical relevance of MET and ALK in Ewing sarcomas.
47. In vitro drug response and efflux transporters associated with drug resistance in pediatric high grade glioma and diffuse intrinsic pontine glioma.
48. Genetics and pharmacogenomics of diffuse gliomas.
49. Guideline on the requirements of external quality assessment programs in molecular pathology.
50. Bone marrow histology in patients with a paroxysmal nocturnal hemoglobinuria clone correlated with clinical parameters.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.